Antineoplastics and oncology agents are pharmaceutical compounds used in the treatment of cancer.
Our high-purity oncology APIs are manufactured under strict quality control standards, ensuring superior purity and consistency for therapeutic applications in various types of cancer treatment, including targeted therapy, chemotherapy, and precision medicine approaches.
Nilotinib
Tyrosine kinase inhibitor (used in chronic myeloid leukemia)
Sorafenib
Tyrosine kinase inhibitor (used in cancer treatment)
Ibrutinib
BTK inhibitor (used in certain types of blood cancers)
Ixazomib Citrate
Proteasome inhibitor (used in multiple myeloma)
Palbociclib
CDK4/6 inhibitor (used in breast cancer)